Dr. Agarwal earned his MBBS degree from All India Institute of Medical Sciences (AIIMS), New Delhi in 1986. After completing his residency in Medicine from AIIMS in 1989, he was a Chief Resident at the same Institute for one year. In 1993 he completed a Nephrology Fellowship from University of Texas, Southwestern Medical Center, Dallas and repeated an Internal Medicine Residency at Presbyterian Hospital of Dallas under Dr. James P. Knochel. He joined the faculty of Indiana University in 1996 where he is currently Professor of Medicine. He is also a Staff Physician at the Roudebush VA Medical Center, Indianapolis, IN.

Dr. Agarwal’s scientific investigations focus in the area of hypertension in hemodialysis. He has refined the definition of hypertension in hemodialysis patients, performed epidemiologic studies to estimate the prevalence, treatment and control of hypertension in hemodialysis and discovered novel techniques for the treatment of hypertension in these patients. Dr. Agarwal has independent NIH support to study hypertension in hemodialysis patients and is recognized as an expert in this field.

He was among the first to demonstrate the effect of add-on angiotensin receptor blockade on cytokine production, oxidative stress, and its effects on proteinuria in patients with chronic kidney disease. He has developed a technique for measurement of oxidative stress biomarkers using HPLC and applied this method to demonstrate generation of oxidative stress when intravenous iron is administered to patients with chronic kidney disease. These observations were amongst the first to demonstrate the presence of oxidative stress in the progression of renal disease in humans and are the subject of his active research.

Dr. Agarwal is a Fellow of the American Heart Association, Fellow of the American Society of Nephrology and an ASH Certified Hypertension Specialist. He serves on the editorial board of Kidney International, American Journal of Nephrology, Seminars in Dialysis, World Scientific Journal and Current Clinical Pharmacology. He is an Associate Editor of NephSAP. He is a recipient of the American Society of Hypertension, Young Scholar’s Award and Indiana University Trustee Teaching Award.